Drug intelligence / Profile preview

AAV.7m8.CaMeRaOpsin GTx

Development stage
Preclinical
Lead developer
Adverum Biotechnologies
Modality
Gene Therapies
Administration
Ophthalmic
01

Overview

AAV.7m8.CaMeRaOpsin GTx is a preclinical optogenetic gene therapy being developed by Adverum Biotechnologies for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The therapy utilizes the AAV.7m8 vector, a proprietary adeno-associated virus variant engineered through directed evolution for efficient retinal transduction following intravitreal injection. The payload is "CaMeRaOpsin," a light-sensitive opsin protein designed to confer photosensitivity to surviving retinal cells, such as bipolar cells or retinal ganglion cells, in areas where photoreceptors have been lost. This approach aims to restore visual function by bypassing damaged photoreceptors and creating a new light-sensing layer within the retina, potentially offering a restorative treatment for patients with advanced retinal degeneration.

Other names
CaMeRaOpsin GTx
02

Targets

Chimeric optogenetic opsin

Beyond the preview

Go deeper on AAV.7m8.CaMeRaOpsin GTx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAV.7m8.CaMeRaOpsin GTx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call